SOURCE: XTend Medical Corporation

November 03, 2009 12:55 ET

XTend Medical Corporation (XMDC) Retains Carl Duncan, Esq., to Handle Company's Legal Strategy and Affairs

SUN VALLEY, CA--(Marketwire - November 3, 2009) - XTend Medical Corporation (PINKSHEETS: XMDC), a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, announced today the company has retained Mr. Carl Duncan, Esq., to become corporate counsel and to handle the filings necessary for the company to migrate to the OTC Bulletin Board trading market.

"We're extremely pleased that Mr. Duncan has agreed to serve as our independent corporate counsel and securities attorney to handle all of our legal strategies and affairs. He will also be handling all the filings necessary for XTend Medical to apply for a listing on the OTC Bulletin Board trading markets upon completion of our company's audited financials. Mr. Duncan has over 37 years' experience in corporate securities law and has represented more than 350 issuers in as many as 48 states concurrently and in an aggregate of 15 countries. Our continued work with Mr. Duncan will spearhead our proposed upcoming listing to the Bulletin Board will be done in accordance with all securities laws and his knowledge in international securities will also serve XTend well as we seek listings, in due course, on other capital markets globally," stated Mr. Paul D. Lisenby, CEO of XTend Medical.

About XTend Medical Corporation

XTend Medical Corporation is a company that specializes in the manufacturing and distribution of the latest in telemedicine and telehealth solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their continued efforts in identifying global companies with true product potential in the healthcare industry puts them in an advantageous position to capitalize on a global basis. For further information, please contact them at info@bioharpunius.com

The new website can be located at www.bioharpunius.com

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

Contact Information